News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.

Ultrapotent, nanoparticle COVID-19 vaccine with Univ. of Wash. roots gets $173M for human trials
An ultrapotent, second-generation COVID-19 vaccine candidate developed by the University of Washington Medicine’s Institute for Protein Design and South Korea-based SK bioscience received $173.4 million

Fueled by COVID drug manufacturing revenues, CDMO Jubilant HollisterStier invests in upgrades, expansion
Spokane-based Jubilant HollisterStier announced a $92 million expansion plan to its existing manufacturing lines, which will allow the company to increase capacity by 50%. The

Seattle’s Eliem Therapeutics raises $60M to advance drug pipeline
Eliem Therapeutics raised $60 million in a Series B funding round to advance its pipeline of clinical and preclinical drugs, following closely on the heel

How Seattle Seeded A Life Sciences Boom
Seattle has long been known as a tech hub – but now, it’s poised for a life science boom. With lab space increasingly hard to

Sana Biotechnology sets sights on growth after $587.5M IPO
Following a banner year for Sana Biotechnology, which saw the company bring in one of the largest IPOs in biotech history, CEO Steve Harr is

New accelerator in Seattle: Creative Destruction Lab to launch ‘deep tech’ startup hub with Microsoft, UW
Creative Destruction Lab, a nonprofit that runs nine startup accelerators across the world, is opening a new outpost in Seattle. The 9-month program, set to

Bristol Myers “dual immunotherapy” beats Opdivo alone in melanoma study
Bristol Myers Squibb reported promising news on its experimental cancer immunotherapy relatlimab after late-stage clinical data showed that when combined with the company’s blockbuster drug

Seattle company launches coronavirus vaccine trial in India
HDT Bio, a Seattle-based biotech company, is taking steps to address rising COVID-19 cases in India by introducing a new vaccine candidate that works similar

Grandson of Jonas Salk raises cash to find ‘genetic needles in the haystack’
Seattle gene-sequencing startup TwinStrand Biosciences raised $50 million in a Series B round, bringing its total funding to $70 million. The company, which spun out

New high-tech lab at Fred Hutch creates 3D maps of proteins to aid therapeutics and vaccine research
A new lab has launched at the Fred Hutchinson Cancer Research Center to facilitate the cryogenic electron microscopy (cryo-EM) technique, which uses extreme temperatures and

Prevencio links with Atlas Genomics to roll out AI-powered blood tests for heart disease
Prevencio, a Kirkland, Washington-based biotechnology company, will partner with Atlas Genomics’ molecular diagnostic laboratory in Seattle to support the commercial rollout of Prevencio’s HART blood

Medical device startup Nanodropper raises $1.4M for eye drop bottle adapter
Nanodropper, a medical device startup founded by University of Washington and Seattle University graduates, announced that it received $1.4 million in seed funding. The company’s
